← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 1999Last known activity
Feb 1, 2025
Timeline
1970s
- Jan 1, 1973
Australasian Leukaemia and Lymphoma Group— Founded
Drugs by trial phase (31 distinct, 13 trials)
Phase 3 (12 own, 0 via acquisition)
Phase 2 (15 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT06664879CollaboratorPhase 1/Phase 2Feb 1, 2025
- NCT06287398Lead sponsorPhase 2Dec 11, 2023
- NCT05833763Lead sponsorPhase 2Apr 30, 2023
- NCT05583552CollaboratorPhase 2Dec 31, 2022
- NCT02001818Lead sponsorPhase 2Apr 1, 2014
- NCT01843868Lead sponsorN/AMay 1, 2013
- NCT00140582CollaboratorPhase 3Dec 1, 2004
- NCT00053092CollaboratorPhase 2Oct 1, 2002
- NCT00049595CollaboratorPhase 3Aug 1, 2002
- NCT00193973CollaboratorPhase 2Jul 1, 2001
- NCT00141648CollaboratorN/ASep 1, 2000
- NCT00115700CollaboratorPhase 3Feb 1, 2000
- NCT00004179CollaboratorPhase 3May 1, 1999
Details
- Founded
- Canberra, AU Jan 1, 1973
- Last known activity
- Feb 1, 2025